1. Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture models
   Andreia S. Barros et al, 2018, International Journal of Pharmaceutics CrossRef
2. mRNA, microRNA and lncRNA as novel bladder tumor markers
   Edyta Wieczorek et al, 2018, Clinica Chimica Acta CrossRef
3. Targeting immunotherapy for bladder cancer using anti‐CD3× B7‐H3 bispecific antibody
   Wanru Ma et al, 2018, Cancer Medicine CrossRef
4. Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer
   Bo Li et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
5. The potential role of c-MYC and polyamine metabolism in multiple drug resistance in bladder cancer investigated by metabonomics
   Yiming Zhu et al, 2022, Genomics CrossRef
6. Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery
   Yoo Kang et al, 2023, Pharmaceutics CrossRef
7. Resveratrol and cancer treatment: updates
   Zhengdong Jiang et al, 2017, Annals of the New York Academy of Sciences CrossRef
8. Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
   Si-Xia Wu et al, 2023, Critical Reviews in Food Science and Nutrition CrossRef
9. FooDrugs: a comprehensive food–drug interactions database with text documents and transcriptional data
   Blanca Lacruz-Pleguezuelos et al, 2023, Database CrossRef
10. Targeting Major Signaling Pathways of Bladder Cancer with Phytochemicals: A Review
    Connor Chestnut et al, 2021, Nutrition and Cancer CrossRef
11. A comprehensive review of the health perspectives of resveratrol
    Abdur Rauf et al, 2017, Food & Function CrossRef
12. Improvement of Cancer Therapy Using Phytochemicals
    Madhumita Roy et al, 2019, Cancer Genetics and Therapeutics CrossRef
13. Role of Curcumin and (−)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review
    Ludwika Piwowarczyk et al, 2020, Cancers CrossRef
14. Reduction of breast tumor drug resistance by 2,3,5,4’-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect
    Yao-Yuan Chang et al, 2021, PLOS ONE CrossRef
15. Protective impact of resveratrol in experimental rat model of hyperoxaluria
    Taylan Oksay et al, 2017, International Urology and Nephrology CrossRef
16. Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer
    Khushbukhat Khan et al, 2020, Cancer Cell International CrossRef
17. Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells
    Chul Yung Choi et al, 2022, Nutrients CrossRef
18. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer
    Xue Jiang et al, 2018, Technology in Cancer Research & Treatment CrossRef
19. Focus on the Use of Resveratrol in Bladder Cancer
    Alessandro Zucchi et al, 2023, International Journal of Molecular Sciences CrossRef
20. Natural products for combating multidrug resistance in cancer
    Ting Chen et al, 2024, Pharmacological Research CrossRef
21. Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: Cancer, Diabetes, and Cardiovascular Disease
    Subhamoy Banerjee, 2020, Plant-derived Bioactives CrossRef
22. Resveratrol effects in bladder cancer: A mini review
    Tamires Cunha Almeida et al, 2021, Genetics and Molecular Biology CrossRef
23. Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells
    Jeong Moon et al, 2018, Nutrients CrossRef